Efekti i procedurave terapeutike në nivelin e triglicerideve te pacientët me diabet tip 2 dhe parodontopati kronike

To monitor blood triglyceride (TRG) values in patients with and without type 2 diabetes mellitus (T2DM) and chron- ic periodontitis (CP) after conservative therapy (scaling and root planning – SRP) with and without laser light ap- plication (low-level laser therapy – LLLT). A total of 120 pa- tients with type 2 diabetes mellitus (T2DM) and diagnosed chronic periodontitis (CP), where the clinical attachment loss (CAL) is ≥4 mm on at least 50% of the affected teeth, were followed. The patients were 35 – 60 years, distribut- ed in three groups A, B and C, 40 in each group. Group A consisted of patients with T2DM and CHP, where conserva- tive periodontal treatment was carried out, supplemented with laser therapy (i.e. T2DM + CP – SRP and LLLT). Group B, where T2DM and CP were diagnosed, consisted of patients treated only with SRP, without application of laser light without laser therapy (i.e. T2DM+ CP – SRP without LLLT). The group C consisted of patients diagnosed with CP, but without T2DM. In all subjects, the values of triglycerides in blood were determined with standard procedure, and then mathematically calculated. The values of TRG in blood in the group A, and the group C after 6 weeks of therapy are significantly lower than the values at the first examination. In the group B the value of TRG in blood after 6 weeks of therapy is in- significantly lower than the value at the first examination. In the group A, the value of TRG in blood after 3 months of therapy and in the group B is insignificantly lower than the value at the first examination in patients. After 3 months of therapy in the group C, the registered value is significantly lower than the value at the first examination. The blood TRG value in the group A 3 months after the therapy is insignificantly higher than the value after 6 weeks of therapy. In the group B and the group C blood TRG value is insignificantly lower than the value at six weeks after therapy. At patients with and without T2DM and CP, regardless of whether they were treated with SRP and LLLT or with SRP, without LLLT, a significant correction of blood TRG was recorded after 6 weeks, and insignificant after 3 months of treatment. SRP and LLLT treat- ment showed the highest effect in the group of patients without T2DM and CP.